Leukemia Purpura and Petechiae: What the Spots Mean

·

Share

In leukemia, petechiae (pinpoint red or purple dots) and purpura (larger purple patches) appear because leukemic cells crowd the bone marrow and it can no longer make enough platelets. With too few platelets, tiny blood vessels leak under the skin. These spots do not fade when pressed, and when they appear without an obvious reason, particularly alongside tiredness, infections, or bruising, they need a prompt blood test.

What Are Petechiae and Purpura?

Both are small areas of bleeding into the skin or the lining of the mouth. They differ mainly in size. In hematology, size helps point to the likely cause.

Finding Typical size Appearance
Petechiae Less than 2 mm Flat, pinpoint red, purple, or brown dots, often in clusters
Purpura About 2 mm to 1 cm Flat purple or red patches
Ecchymoses (bruises) Larger than 1 cm Blue, purple, or yellow-green patches

A simple check is the blanch test: press a clear glass against the spots. A rash from dilated blood vessels fades under pressure, while petechiae and purpura stay visible because the blood has leaked out of the vessels. Our article on leukemia purpura looks at this sign in more depth.

Why Leukemia Causes These Spots

Crowded bone marrow and low platelets

Leukemia is a cancer of blood-forming cells in which abnormal, immature white cells called blasts multiply uncontrollably. As they fill the marrow, they crowd out the megakaryocytes that normally produce platelets, a process described in our piece on platelet production.

The result is thrombocytopenia, an abnormally low platelet count. A normal count runs from about 150,000 to 450,000 per microliter. Spontaneous petechiae and purpura usually appear only when the count has fallen well below that range, and the risk of spontaneous bleeding rises considerably below about 20,000.

Other contributing mechanisms

  • Platelet dysfunction: in some leukemias, the platelets that are made do not work normally. See our overview of platelet dysfunction.
  • Disseminated intravascular coagulation (DIC): widespread activation of clotting that uses up platelets and clotting factors. It is classically associated with acute promyelocytic leukemia, a subtype treated as a medical emergency.
  • Treatment effects: chemotherapy suppresses the marrow further, so counts often dip during treatment even as the leukemia responds.
  • Infection: severe infections can consume platelets and damage small blood vessels.

Acute versus chronic leukemia

Skin bleeding is far more typical of acute leukemia, where blasts build up over weeks and platelet counts can fall quickly. In chronic leukemias, such as chronic lymphocytic leukemia, the marrow is often affected more slowly, so petechiae tend to appear later in the illness or when immune destruction of platelets develops. In either case, new spots are a reason to recheck the blood count rather than wait.

Signs, Symptoms, and Where Spots Appear

Petechiae often show up first on the lower legs and ankles, where gravity increases pressure in small vessels. They are also common inside the mouth, on the soft palate, and around the eyes after coughing or vomiting. Purpura may appear on the arms, legs, or trunk.

Because leukemia affects all blood cell lines, skin spots rarely come alone. Other features include:

  • Fatigue, pale skin, and breathlessness from anemia
  • Frequent or slow-to-clear infections and fevers from a lack of working white cells
  • Bleeding gums, nosebleeds, heavy periods, or prolonged bleeding from small cuts
  • Bone or joint pain, swollen lymph nodes, or a full feeling under the left ribs from an enlarged spleen

Leukemia is only one cause of these spots. Many bleeding disorders, as well as infections, some medicines, immune thrombocytopenia, vasculitis, and even forceful coughing or vomiting, can produce petechiae. The combination of symptoms is what raises concern.

How Leukemia Is Diagnosed

Blood tests

A complete blood count (CBC) is the first step. In leukemia it may show a high, normal, or low white cell count, together with anemia and a low platelet count. A peripheral blood smear lets a specialist look for blasts under the microscope. Clotting tests such as PT, aPTT, and fibrinogen are added when DIC is suspected.

Bone marrow and specialist testing

A bone marrow aspirate and biopsy confirm the diagnosis by showing the proportion and type of abnormal cells. Flow cytometry, cytogenetics, and molecular testing then classify the leukemia precisely, which guides treatment. Our guide to diagnosing leukemia walks through each step.

Treatment and Supportive Care

Treating the leukemia

Skin bleeding settles when normal blood production returns, so the main treatment is the leukemia itself. Depending on the type, this may involve chemotherapy, targeted drugs, immunotherapy, or stem cell transplantation. For example, tyrosine kinase inhibitors such as imatinib and dasatinib are used for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Chimeric antigen receptor (CAR) T-cell therapy is an option for some relapsed B-cell leukemias. Our overview of leukemia treatment covers these approaches, and our leukemia guide gives broader context on the disease.

Managing bleeding risk

Platelet transfusions are given to prevent bleeding when counts are very low, commonly below 10,000 per microliter in stable patients, and at higher levels when there is fever, active bleeding, or a planned procedure. Antifibrinolytic medicines such as tranexamic acid can help with mucosal bleeding, such as from the gums or nose, in selected situations. DIC is treated urgently with blood products and prompt leukemia-directed therapy.

Practical precautions at home

  • Use a soft toothbrush and an electric razor
  • Avoid aspirin and anti-inflammatory painkillers unless your team approves them
  • Avoid contact sports and activities with a high risk of falls
  • Photograph new spots so your team can compare changes over time

When to See a Doctor

See a doctor promptly if you notice petechiae or purpura without a clear cause, especially with fatigue, fever, bruising, or bleeding gums. Seek emergency care for spreading spots with fever, a severe headache, confusion, blood in vomit, urine, or stool, or bleeding that will not stop. In people already being treated for leukemia, new spots can mean the platelet count has dropped and should be reported the same day. Early testing matters because many hematological disorders respond best when treated early.

Frequently Asked Questions

What do leukemia spots look like?

They are usually flat, pinpoint red, purple, or brownish dots, often clustered on the lower legs or inside the mouth. Larger purple patches (purpura) and unexplained bruises may appear too. They do not fade when pressed.

Do petechiae always mean leukemia?

No. Most petechiae have other causes, such as viral infections, medicines, immune thrombocytopenia, or straining from coughing or vomiting. A blood count quickly shows whether platelets are low and whether further tests are needed.

Can petechiae be the first sign of leukemia?

Yes, they can be an early sign, particularly in acute leukemia. They usually appear alongside other symptoms such as tiredness, pallor, or infections.

Will the spots go away after treatment?

Existing spots fade over one to two weeks as the blood is reabsorbed. New spots stop forming once platelet counts recover, either through transfusion or as treatment brings the leukemia under control.

Written by
Bone Marrow Biology, Haematology, Leukaemia, Oncology
Contact [email protected] vangalenlab Website Brigham and Women’s Hospital and Harvard Medical School March 30, 2020 Tracing clonal evolution in myeloid malignancies using single-cell sequencing The van Galen laboratory at Brigham and Women’s Hospital and Harvard Medical School focuses on normal and malignant hematopoiesis. We use experimental and computational innovations to study the complex processes that maintain the blood system and…
View Full Profile →
Web Admin Avatar